Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bioxcel Therapeutics Inc
(NQ:
BTAI
)
0.6790
+0.0269 (+4.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bioxcel Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Expert Ratings for BioXcel Therapeutics
November 15, 2023
Via
Benzinga
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 14, 2023
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.
Via
Benzinga
Why Is Dementia Focused BioXcel Therapeutics Stock Trading Lower Today?
November 14, 2023
BioXcel Therapeutics Inc (NASDAQ: BTAI) announced alignment with the FDA's recommendation for a Phase 3 trial in the TRANQUILITY program of BXCL501 for acute treatment of agitation associated
Via
Benzinga
Recap: BioXcel Therapeutics Q3 Earnings
November 14, 2023
Via
Benzinga
Earnings Outlook For BioXcel Therapeutics
November 13, 2023
Via
Benzinga
Where BioXcel Therapeutics Stands With Analysts
September 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 14, 2023
Via
Benzinga
BioXcel Therapeutics Reveals Survival Data From Prostate Cancer Combo Therapy Trial
November 08, 2023
BioXcel Therapeutics Inc (NASDAQ: BTAI) announced overall survival (OS) data from its Phase 2 trial of BXCL701 in combination with Merck & Co Inc's (NYSE: MRK) Keytruda (pembrolizumab) in patients wi
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 30, 2023
Via
Benzinga
Dow Falls Over 100 Points; Alphabet Shares Tumble After Q3 Results
October 25, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 100 points on Wednesday. The Dow traded down 0.35% to 33,025.71 while the NASDAQ fell 2.45% to 12,817.76....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Analyst Expectations for BioXcel Therapeutics's Future
August 15, 2023
Via
Benzinga
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 25, 2023
Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 25, 2023
Via
Benzinga
Shell Layoffs 2023: What to Know About the Latest SHEL Job Cuts
October 25, 2023
Shell layoffs are on the horizon as the petrol company prepares to cut 200 jobs in 2024 with another 130 jobs under review.
Via
InvestorPlace
Topics
Energy
Workforce
Exposures
Fossil Fuels
Layoff
EVGO Stock Slips as TD Cowen Downgrades EVgo
October 25, 2023
EVgo stock is taking a beating on Wednesday as investors in the EV charging company deal with a downgrade and price cut.
Via
InvestorPlace
Nasdaq Down 1.5%; Microsoft Posts Upbeat Results
October 25, 2023
U.S. stocks traded lower this morning, with the Nasdaq Composite falling 1.5% on Wednesday. Following the market opening Wednesday, the Dow traded down 0.26% to 33,053.68 while the NASDAQ fell 1.50% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is BioXcel Therapeutics (BTAI) Stock Up 42% Today?
October 25, 2023
BioXcel Therapeutics stock is rising on Wednesday as investors in BTAI stock react to results from an audit on a clinical trial.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 25, 2023
Via
Benzinga
Schizophrenia Player BioXcel's Drug Faces Funding Headwinds, Analyst Downgrades Stock
October 05, 2023
Truist downgraded BioXcel Therapeutics Inc (NASDAQ: BTAI) from Buy to Hold, citing significant near-term funding and
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023
October 05, 2023
Via
Benzinga
Why Shares of BioXcel Therapeutics Fell This Week
September 28, 2023
The company's co-founder is leaving, and layoffs are coming.
Via
The Motley Fool
Topics
Workforce
Exposures
Layoff
Why BioXcel Therapeutics Stock Flopped Again Today
August 15, 2023
Major changes are afoot with the company, and few are happy about them.
Via
The Motley Fool
Challenging Horizon For BioXcel: Analysts Dive Into Igalmi's Potential And Reshaped Commercialization Strategy
August 15, 2023
Mizuho analyst Graig Suvannavejh downgraded BioXcel Therapeutics, Inc. (NASDAQ: BTAI) to Neutral from Buy,
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
August 15, 2023
Via
Benzinga
NVIDIA To Rally More Than 23%? Here Are 10 Other Analyst Forecasts For Tuesday
August 15, 2023
B of A Securities lowered the price target for Valero Energy Corporation (NYSE: BMBL) from $160 to $152. B of A Securities analyst Doug Leggate downgraded the stock from Buy to Neutral. Valero Energy...
Via
Benzinga
Crude Oil Down 1%; Zynerba Pharmaceuticals Shares Spike Higher
August 14, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 90 points on Monday. The Dow traded down 0.14% to 35,232.62 while the NASDAQ rose 0.66% to 13,735.42. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
August 14, 2023
Via
Benzinga
3 Biotech Stocks to Sell in August Before They Crash and Burn
August 14, 2023
These biotech stocks are set to crash and burn, so it's probably a good idea for investors to sell in August, before it's too late.
Via
InvestorPlace
Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 14, 2023
Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration...
Via
Benzinga
US Stocks Turn Higher; BioXcel Therapeutics Shares Plummet
August 14, 2023
U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining more than 80 points on Monday. The Dow traded up 0.01% to 35,284.34 while the NASDAQ rose 0.64% to 13,732.05....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.